Active
Overview
- Legal name
- CURIA GLOBAL INC
- Registered location
- ALBANY, NY, USA
- Website
- Company website ↗
- Primary NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Latest award activity
- Sep 11, 2026
Read company summary
CURIA GLOBAL INC is associated with UEI ELCNZCS8GEA3 and CAGE 3D1R9 in public federal records. AcornBids currently links 33 prime awards totaling $43.0M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); Pharmaceutical Preparation Manufacturing; Medicinal and Botanical Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)). Its public SAM.gov registration lists ALBANY, NY, USA.
At a glance
Lifetime prime obligations$43.0M
Prime awards33
Awards with future end dates7
Top-agency concentration100.0%
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 11, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- CURIA GLOBAL INC
- UEI
- ELCNZCS8GEA3
- CAGE
- 3D1R9
- Registered address
- 21 CORPORATE CIR, ALBANY, NY, 12203, USA
- Registration status
- Active
- Primary NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM activation
- May 20, 2026
- Initial registration
- Mar 6, 2003
- Entity start
- Jun 15, 1991
- SAM updated
- Jul 6, 2026
- Registration expires
- May 18, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 33 awards and $42,957,945 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (NAICS 541715); this classification is not proof of every company capability. Source
- An example award describes: IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16) Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Selected transaction obligations$21.2M
Prime contracts
$22.2KFY2015$27.4KFY2016$28.2KFY2017$64.9KFY2018$47.5KFY2019$1.4MFY2020$909.0KFY2021$2.1MFY2022$4.6MFY2023$8.2MFY2024$2.5MFY2025$1.4MFY2026
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 33 of 33 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $1.4M |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $2.5M |
| Change | $-1.1M |
| Growth | -44.5% |
Where the work is performed
AKMEVTNHWAIDMTNDMNWIMINYMAORNVWYSDIAILINOHPANJCTRICAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCDCOKLAMSALGAHITXFL
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Health and Human Services | $21.2M | 33 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| NATIONAL INSTITUTES OF HEALTH NIDA | $18.8M | 28 |
| NATIONAL INSTITUTES OF HEALTH NIAID | $2.3M | 4 |
| NATIONAL INSTITUTES OF HEALTH OLAO | $72.0K | 1 |
Naics
Psc
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| HHSN271201800001I | $11.0M | 15 |
| HHSN271201500005I | $5.0M | 8 |
| 75N93018D00008 | $2.3M | 4 |
| HHSN271201700005I | $1.9M | 3 |
| Unclassified | $956.0K | 3 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $20.2M | 30 |
| NO SET ASIDE USED. | $956.0K | 3 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| HHSN27100001IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16) | Department of Health and Human Services | $273.1K | Jan 15, 2015 | Jan 14, 2025 |
| HHSN27100001IGF::OT::IGF TASK ORDER NO. 0001 - MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP | Department of Health and Human Services | $173.7K | Mar 16, 2018 | Mar 15, 2027 |
| 75N98026P01289NINDS: MEDICINAL CHEMISTRY | Department of Health and Human Services | $72.0K | Aug 14, 2026 | Aug 13, 2027 |
| 75N95023F00001KATRITCH- UNIVERSITY OF SOUTHERN CALIFORNIA DMFP FOR BPN-35269 - CURIA GLOBAL, INC. | Department of Health and Human Services | $2.5M | Sep 13, 2023 | Sep 12, 2029 |
| 75N95024P00489CGMP MITRAGYNINE HCL SUPPLEMENTAL STABILITY & ANALYTICAL ACTIVITIES | Department of Health and Human Services | $96.2K | Sep 9, 2024 | Sep 8, 2027 |
| 75N93020F00003NONCLINICAL SERVICES - SCALE-UP SYNTHESIS OF APX2039, A NOVEL GWT1 ENZYME INHIBITOR IN FUNGI | Department of Health and Human Services | $620.1K | Aug 27, 2020 | Sep 30, 2021 |
| 75N95024P00615NON-GMP SYNTHESIS OF COMPOUNDS. POP: 9/19/24-9/18/25. | Department of Health and Human Services | $884.0K | Sep 19, 2024 | Sep 18, 2027 |
| 75N95019F00088ALBANY MOLECULAR RESEARCH, INC: WAGNER UCSD-0776890 ICH STABILITY STUDY. DMFP. | Department of Health and Human Services | $71.9K | Sep 9, 2019 | Apr 30, 2022 |
| 75N95019F00089ALBANY MOLECULAR RESEARCH INC - BOZIK BPN 25203 | Department of Health and Human Services | $1.9M | Sep 10, 2019 | Sep 12, 2024 |
| 75N95020F00001ALBANY MOLECULAR RESEARCH INC:1106422 [20-006949] | Department of Health and Human Services | $142.8K | Sep 15, 2020 | Jun 4, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jul 6, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Mar 6, 2003 |
| Entity start | Jun 15, 1991 |
| Industry | Reported size status |
|---|---|
| 325199 — All Other Basic Organic Chemical Manufacturing | Not reported |
| 325411 — Medicinal and Botanical Manufacturing | Not reported |
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| 325414 — Biological Product (except Diagnostic) Manufacturing | Not reported |
| 325998 — All Other Miscellaneous Chemical Product and Preparation Manufacturing | Not reported |
| 541380 — Testing Laboratories and Services | Not reported |
| 541690 — Other Scientific and Technical Consulting Services | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| KATHLEEN BOVE | Government business | Contact method not published | SAM registration | Not available |
| SAMANTHA CONNELLY | Alternate government business | Contact method not published | SAM registration | Not available |
| ANSLEY GUTIERREZ | Electronic business | Contact method not published | SAM registration | Not available |
| AMY BONACQUISTI | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325199 — All Other Basic Organic Chemical Manufacturing
- 325411 — Medicinal and Botanical Manufacturing
- 325412 — Pharmaceutical Preparation Manufacturing
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- 325414 — Biological Product (except Diagnostic) Manufacturing
- 325998 — All Other Miscellaneous Chemical Product and Preparation Manufacturing
- 541380 — Testing Laboratories and Services
- 541690 — Other Scientific and Technical Consulting Services
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
9 awards
9 awards
20 awards
7 awards
3 awards
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit